New Brunswick, N.J. – A number of physicians at Rutgers Cancer Institute of New Jersey – the state’s only National Cancer Institute-designated Comprehensive Cancer Center – have been recognized by New Jersey Monthly magazine as a ‘Jersey Choice Top Doctor.’
“These physicians represent the extraordinary clinical care provided to patients at Rutgers Cancer Institute of New Jersey. Their compassionate manner and exceptional expertise in their specialty area complements that of their multidisciplinary teams comprised of physicians and researchers working to advance the future of cancer care and scientific discovery. We greatly appreciate this recognition of our team’s unwavering dedication to carrying out this mission,” Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services for RWJBarnabas Health and vice chancellor for cancer programs at Rutgers Biomedical and Health Sciences, Rutgers University.
Thousands of New Jersey-based doctors were asked to give physician recommendations, which were researched by an independent firm commissioned by the magazine to conduct the 2018 survey.
Rutgers Cancer Institute physicians on this year’s list are also faculty members at Rutgers Robert Wood Johnson Medical School and practice at Rutgers Cancer Institute’s flagship hospital Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Those named to the 2018 list are:
- David A. August, MD, Section Chief, Gastrointestinal Surgical Oncology; specialty: gastrointestinal malignancies
- M. Michele Blackwood, MD, FACS, Chief; Breast Surgery, Rutgers Cancer Institute; Medical Director and Northern Regional Director, Breast Services, RWJBarnabas Health; specialty: breast cancer and complex breast malignancies
- Richard Drachtman, MD, Section Chief, Pediatric Hematology/Oncology; specialty: pediatric cancers and blood disorders
- Sammy Elsamra, MD, urologic oncologist; specialty: robotic and laparoscopic urologic surgery; percutaneous renal surgery; prostate, kidney and bladder cancers
- John Langenfeld, MD, Co-Director, Thoracic Oncology Program; specialty: lung cancer, esophagus cancer, tumors of the chest wall
- Lorna Rodriguez, MD, PhD, Chief, Gynecologic Oncology specialty: gynecologic cancers and precision medicine
- Roger Strair, MD, PhD, Chief, Division of Blood Disorders; specialty: leukemia, lymphoma, blood and marrow transplants
A full listing of ‘Top Doctors’ can be found at https://njmonthly.com/find-a-doctor/. Full profiles of Rutgers Cancer Institute doctors named to the list can be found at http://cinj.org/physician-profile/search.
About Rutgers Cancer Institute of New Jersey
As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including bone marrow transplantation, proton therapy and CAR-T cell therapy. Along with clinical trials and novel therapeutics such as precision medicine and immunotherapy – many of which are not widely available – patients have access to these cutting-edge therapies at Rutgers Cancer Institute of New Jersey in New Brunswick, Rutgers Cancer Institute of New Jersey at University Hospital in Newark, as well as through RWJBarnabas Health facilities.
Along with world-class treatment, which is often fueled by on-site research conducted in Rutgers Cancer Institute laboratories, patients and their families also can seek cancer preventative services and education resources throughout the Rutgers Cancer Institute and RWJBarnabas Health footprint statewide. To make a tax-deductible gift to support the Cancer Institute of New Jersey, call 848-932-8013 or visit www.cinj.org/giving.
For journalists – contact:
Michele Fisher, Media Relations Specialist
For patient appointments/inquiries – contact: